Literature DB >> 23148524

A homozygous mutation of voltage-gated sodium channel β(I) gene SCN1B in a patient with Dravet syndrome.

Ikuo Ogiwara1, Tojo Nakayama, Tetsushi Yamagata, Hideyuki Ohtani, Emi Mazaki, Shigeru Tsuchiya, Yushi Inoue, Kazuhiro Yamakawa.   

Abstract

Dravet syndrome is a severe form of epileptic encephalopathy characterized by early onset epileptic seizures followed by ataxia and cognitive decline. Approximately 80% of patients with Dravet syndrome have been associated with heterozygous mutations in SCN1A gene encoding voltage-gated sodium channel (VGSC) α(I) subunit, whereas a homozygous mutation (p.Arg125Cys) of SCN1B gene encoding VGSC β(I) subunit was recently described in a patient with Dravet syndrome. To further examine the involvement of homozygous SCN1B mutations in the etiology of Dravet syndrome, we performed mutational analyses on SCN1B in 286 patients with epileptic disorders, including 67 patients with Dravet syndrome who have been negative for SCN1A and SCN2A mutations. In the cohort, we found one additional homozygous mutation (p.Ile106Phe) in a patient with Dravet syndrome. The identified homozygous SCN1B mutations indicate that SCN1B is an etiologic candidate underlying Dravet syndrome. Wiley Periodicals, Inc.
© 2012 International League Against Epilepsy.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23148524     DOI: 10.1111/epi.12040

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  28 in total

Review 1.  Sodium channel β subunits: emerging targets in channelopathies.

Authors:  Heather A O'Malley; Lori L Isom
Journal:  Annu Rev Physiol       Date:  2015       Impact factor: 19.318

2.  GABRA1 and STXBP1: novel genetic causes of Dravet syndrome.

Authors:  Gemma L Carvill; Sarah Weckhuysen; Jacinta M McMahon; Corinna Hartmann; Rikke S Møller; Helle Hjalgrim; Joseph Cook; Eileen Geraghty; Brian J O'Roak; Steve Petrou; Alison Clarke; Deepak Gill; Lynette G Sadleir; Hiltrud Muhle; Sarah von Spiczak; Marina Nikanorova; Bree L Hodgson; Elena V Gazina; Arvid Suls; Jay Shendure; Leanne M Dibbens; Peter De Jonghe; Ingo Helbig; Samuel F Berkovic; Ingrid E Scheffer; Heather C Mefford
Journal:  Neurology       Date:  2014-03-12       Impact factor: 9.910

Review 3.  Voltage-gated sodium channel β subunits: The power outside the pore in brain development and disease.

Authors:  Jacob M Hull; Lori L Isom
Journal:  Neuropharmacology       Date:  2017-09-18       Impact factor: 5.250

Review 4.  Ion Channel Genes and Epilepsy: Functional Alteration, Pathogenic Potential, and Mechanism of Epilepsy.

Authors:  Feng Wei; Li-Min Yan; Tao Su; Na He; Zhi-Jian Lin; Jie Wang; Yi-Wu Shi; Yong-Hong Yi; Wei-Ping Liao
Journal:  Neurosci Bull       Date:  2017-05-09       Impact factor: 5.203

5.  Mapping genetic modifiers of survival in a mouse model of Dravet syndrome.

Authors:  A R Miller; N A Hawkins; C E McCollom; J A Kearney
Journal:  Genes Brain Behav       Date:  2013-11-14       Impact factor: 3.449

Review 6.  Mechanisms of sudden unexplained death in epilepsy.

Authors:  Alica M Goldman
Journal:  Curr Opin Neurol       Date:  2015-04       Impact factor: 5.710

7.  Crystallographic insights into sodium-channel modulation by the β4 subunit.

Authors:  John Gilchrist; Samir Das; Filip Van Petegem; Frank Bosmans
Journal:  Proc Natl Acad Sci U S A       Date:  2013-12-02       Impact factor: 11.205

8.  Sudden unexpected death in epilepsy genetics: Molecular diagnostics and prevention.

Authors:  Alica M Goldman; Elijah R Behr; Christopher Semsarian; Richard D Bagnall; Sanjay Sisodiya; Paul N Cooper
Journal:  Epilepsia       Date:  2016-01       Impact factor: 5.864

Review 9.  Mechanisms of epileptogenesis: a convergence on neural circuit dysfunction.

Authors:  Ethan M Goldberg; Douglas A Coulter
Journal:  Nat Rev Neurosci       Date:  2013-04-18       Impact factor: 34.870

Review 10.  Role of Sodium Channels in Epilepsy.

Authors:  David I Kaplan; Lori L Isom; Steven Petrou
Journal:  Cold Spring Harb Perspect Med       Date:  2016-06-01       Impact factor: 6.915

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.